Sign in

You're signed outSign in or to get full access.

STEPAN (SCL)

--

Earnings summaries and quarterly performance for STEPAN.

Recent press releases and 8-K filings for SCL.

Stepan Company Closes Sale of Lake Providence, LA Manufacturing Assets
SCL
M&A
New Projects/Investments
  • Stepan Company (SCL) has closed the sale of its manufacturing assets located in Lake Providence, LA.
  • This transaction is part of Stepan's ongoing footprint optimization efforts and focus on core growth opportunities.
  • The company previously completed a similar divestiture of its plant in the Philippines.
  • The terms of the transaction were not disclosed.
Dec 30, 2025, 9:01 PM
Stepan Announces Agreement to Sell Lake Providence, LA Assets
SCL
M&A
  • Stepan Company (NYSE: SCL) announced an agreement to sell its manufacturing assets located in Lake Providence, LA.
  • This transaction is part of the company's ongoing footprint optimization efforts and focus on core growth opportunities.
  • The parties are targeting to close the transaction before year-end, subject to customary closing conditions, but the terms were not disclosed.
Dec 3, 2025, 12:00 PM
Stepan Company Completes Sale of Philippine Assets
SCL
M&A
  • Stepan Company (SCL) announced the successful closing on November 14, 2025, of the sale of its subsidiary, Stepan Philippines Quaternaries, Inc. (SPQI), manufacturing assets located in Bauan, Batangas, Philippines, to Masurf, Inc.
  • This transaction fulfills SPQI's previously announced Asset Transfer Agreement, dated May 27, 2025, and underscores Stepan's commitment to its strategic priorities to sharpen its focus on core growth assets.
  • As part of the closing, SPQI entered into a tolling agreement with Masurf for the continued service of SPQI customers in Southeast Asia.
  • The terms of the transaction were not disclosed.
Nov 20, 2025, 9:01 PM
Stepan Reports Q3 Sales Increase While Net Income Falls
SCL
Earnings
Revenue Acceleration/Inflection
  • Stepan Company reported third-quarter sales of $590.28 million, an 8% increase from the prior year, driven by strong specialty chemicals and surfactant sales.
  • Despite the sales growth, net income declined to $10.84 million from $23.61 million a year ago, with adjusted earnings per share at $0.48, missing analyst consensus due to higher taxes and rising interest costs.
  • Year-to-date sales reached $1,778.23 million, and adjusted EBITDA increased 9% with volumes up 2%, despite challenges such as increased start-up expenses and rising raw material costs.
  • The company's free cash flow improved to $40.2 million for the quarter, and the CEO highlighted a focus on restoring margins.
Oct 29, 2025, 2:22 PM
Stepan Company Announces Q3 2025 Financial Results
SCL
Earnings
Dividends
New Projects/Investments
  • Stepan Company reported Q3 2025 adjusted EBITDA of $56 million, a 6% increase year-over-year, contributing to a year-to-date adjusted EBITDA of $165 million, up 9%.
  • Adjusted net income for Q3 2025 was $10.9 million ($0.48 per diluted share), representing a 54% decrease from the prior year, mainly due to a higher effective tax rate, increased net interest, and higher depreciation from the Pasadena plant startup, none of which were cash impacts.
  • Total company sales volumes grew 1% in Q3 2025, with Polymers volumes up 8% and the Specialty Products' MCT line growing 26%, while Surfactants volume declined 2%.
  • Free cash flow was positive at $40.2 million for the quarter, driven by working capital reductions and disciplined capital spending, with expectations for positive free cash flow for the full year 2025.
  • The company declared a quarterly cash dividend of $0.395 per share, a 2.6% increase, extending its record of 58 consecutive years of dividend increases. The new Pasadena facility is now fully operational and ramping up production, with full contribution anticipated in 2026.
Oct 29, 2025, 1:00 PM
Stepan Company Announces Q3 2025 Results
SCL
Earnings
Demand Weakening
New Projects/Investments
  • Stepan Company reported Net Income of $10.8 million for Q3 2025, representing a 54% year-over-year decrease, primarily attributed to a higher effective tax rate and increased net interest expenses.
  • Adjusted EBITDA grew 6% year-over-year to $56.2 million in Q3 2025, driven by improved results within the Crop Productivity and Specialty Products businesses.
  • Global sales volume increased 1% year-over-year in Q3 2025, with strong growth across Polymers, Crop Productivity, Industrial Cleaning, and MCT businesses, partially offset by a decline in Global commodity Consumer Surfactants.
  • The company generated positive Free Cash Flow of $40.2 million in Q3 2025, a significant improvement from a negative ($4.0) million in the prior year, primarily due to reductions in working capital.
  • Strategic updates include the continued ramp-up of production at the Pasadena, Texas site and being on track to close the sale of Philippines assets in Q4.
Oct 29, 2025, 1:00 PM
Stepan Company Reports Q3 2025 Financial Results with 6% Adjusted EBITDA Growth
SCL
Earnings
Dividends
Guidance Update
  • Stepan Company reported Q3 2025 adjusted net income of $10.9 million, a 54% decrease year-over-year, and adjusted diluted EPS of $0.48.
  • Adjusted EBITDA for Q3 2025 increased by 6% to $56 million, driven by strong Specialty Products results, partially offset by lower earnings in Surfactants and Polymers. Year-to-date adjusted EBITDA reached $165 million, up 9%.
  • The company achieved positive free cash flow of $40 million in Q3 2025, an increase of $44.2 million year-over-year, primarily due to working capital reductions and disciplined capital spending.
  • Surfactants adjusted EBITDA declined 14% due to higher raw material costs and Pasadena startup expenses, while Specialty Products adjusted EBITDA surged 113%. Total company sales volumes grew 1%.
  • Stepan declared a quarterly cash dividend of $0.395 per share, representing a 2.6% increase, marking its 58th consecutive year of increased dividends. The company anticipates full-year adjusted EBITDA growth and positive free cash flow in 2025.
Oct 29, 2025, 1:00 PM
Stepan Company Reports Q3 2025 Adjusted EBITDA Growth and Positive Free Cash Flow
SCL
Earnings
Dividends
New Projects/Investments
  • Stepan Company reported Q3 2025 adjusted EBITDA of $56 million, a 6% increase year-over-year, contributing to a 9% growth in year-to-date adjusted EBITDA to $165 million.
  • Adjusted net income for Q3 2025 decreased by 54% to $10.9 million, primarily due to a higher effective tax rate, increased net interest, and higher depreciation.
  • The company generated positive free cash flow of $40 million in Q3 2025, driven by working capital reductions and disciplined capital spending.
  • Performance was bolstered by strong Specialty Products results but constrained by higher oil chemical raw material prices affecting surfactant margins and increased startup costs for the new Pasadena, Texas facility.
  • Stepan declared a quarterly cash dividend of $0.395 per share, representing a 2.6% increase and marking 58 consecutive years of dividend growth, and expects to deliver full-year adjusted EBITDA growth and positive free cash flow in 2025.
Oct 29, 2025, 1:00 PM
Stepan Reports Q3 2025 Results
SCL
Earnings
Dividends
Demand Weakening
  • Stepan Company reported net sales of $590.3 million for Q3 2025, an 8% increase year-over-year, with Adjusted EBITDA increasing 6% to $56.2 million.
  • Despite top-line growth, Q3 2025 net income decreased 54% to $10.8 million, resulting in diluted EPS of $0.47, primarily due to a higher effective tax rate, increased interest expense, and an $8.6 million negative impact from start-up costs at its new Pasadena site.
  • The company generated $40.2 million in free cash flow during the quarter and declared a quarterly cash dividend of $0.395 per share, marking its 58th consecutive year of dividend increases.
  • While the Surfactant segment experienced a 14% decline in Adjusted EBITDA due to lower demand in commodity consumer products and start-up expenses, Stepan remains optimistic about delivering full year adjusted EBITDA growth and positive free cash flow in 2025.
Oct 29, 2025, 11:00 AM
Stepan Company Reports Third Quarter 2025 Results
SCL
Earnings
Guidance Update
New Projects/Investments
  • Stepan Company reported net income of $10.8 million for Q3 2025, a 54% decrease year-over-year, with diluted EPS of $0.47, also down 54%. This decline was largely attributed to a higher effective tax rate, increased interest expense, and $8.6 million in higher costs associated with the start-up of the new alkoxylation site in Pasadena, Texas.
  • For the third quarter of 2025, Adjusted EBITDA increased 6% year-over-year to $56.2 million, and free cash flow was $40.2 million.
  • Year-to-date 2025 (nine months ended September 30), Adjusted EBITDA grew 9% to $165.1 million, with global sales volume up 2% year-over-year.
  • Net Sales for Q3 2025 increased 8% to $590.3 million, and year-to-date 2025, net sales rose 7% to $1,778.2 million.
  • The company anticipates delivering full-year Adjusted EBITDA growth and generating positive free cash flow in 2025.
Oct 29, 2025, 11:00 AM